$INCR.OB Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AEOLUS PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AEOLUS PHARMACEUTICALS, INC.. Get notifications about new insider transactions in AEOLUS PHARMACEUTICALS, INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 30 2016 | INCR.OB | AEOLUS PHARMACEUTI ... | McManus John L | President and CEO | Option Exercise | A | 0.19 | 250,000 | 46,375 | 250,000 | |
Dec 30 2016 | INCR.OB | AEOLUS PHARMACEUTI ... | McManus John L | President and CEO | Grant | A | 0.15 | 25,000 | 3,750 | 3,767,047 | 3.7 M to 3.8 M (+0.67 %) |
Feb 08 2016 | INCR.OB | AEOLUS PHARMACEUTI ... | RALLIS CHRIS A | Director | Option Exercise | A | 0.25 | 100,000 | 25,000 | 100,000 | |
Feb 08 2016 | INCR.OB | AEOLUS PHARMACEUTI ... | RALLIS CHRIS A | Director | Option Exercise | A | 0.24 | 100,000 | 24,000 | 100,000 | |
Feb 08 2016 | INCR.OB | AEOLUS PHARMACEUTI ... | RALLIS CHRIS A | Director | Option Exercise | A | 0.26 | 100,000 | 26,120 | 100,000 | |
Feb 03 2016 | INCR.OB | AEOLUS PHARMACEUTI ... | KUMAR AMIT | Director | Option Exercise | A | 0.25 | 100,000 | 25,000 | 100,000 | |
Feb 03 2016 | INCR.OB | AEOLUS PHARMACEUTI ... | KUMAR AMIT | Director | Option Exercise | A | 0.24 | 100,000 | 24,000 | 100,000 | |
Feb 03 2016 | INCR.OB | AEOLUS PHARMACEUTI ... | KUMAR AMIT | Director | Option Exercise | A | 0.26 | 100,000 | 26,120 | 100,000 | |
Feb 03 2016 | INCR.OB | AEOLUS PHARMACEUTI ... | Kaye Mitchell D | Director | Option Exercise | A | 0.26 | 75,000 | 19,590 | 75,000 | |
Feb 03 2016 | INCR.OB | AEOLUS PHARMACEUTI ... | McManus John L | President and CEO | Option Exercise | A | 0.27 | 250,000 | 67,050 | 250,000 | |
Feb 03 2016 | INCR.OB | AEOLUS PHARMACEUTI ... | McManus John L | President and CEO | Option Exercise | A | 0.27 | 250,000 | 66,250 | 250,000 | |
Feb 03 2016 | INCR.OB | AEOLUS PHARMACEUTI ... | Clerici John | Director | Option Exercise | A | 0.25 | 75,000 | 18,750 | 75,000 | |
Feb 03 2016 | INCR.OB | AEOLUS PHARMACEUTI ... | Clerici John | Director | Option Exercise | A | 0.24 | 75,000 | 18,000 | 75,000 | |
Feb 03 2016 | INCR.OB | AEOLUS PHARMACEUTI ... | Clerici John | Director | Option Exercise | A | 0.26 | 75,000 | 19,590 | 75,000 | |
May 13 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | Scott Jeffrey | Director | Option Exercise | A | 0.44 | 75,000 | 33,000 | 75,000 | |
May 10 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | Kaye Mitchell D | Director | Option Exercise | A | 0.44 | 75,000 | 33,000 | 75,000 | |
May 10 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | Cavalier David | Director | Option Exercise | A | 0.44 | 75,000 | 33,000 | 75,000 | |
May 10 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | Suzdak Peter David | Director | Option Exercise | A | 0.44 | 75,000 | 33,000 | 75,000 | |
May 10 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | Krivulka Joseph J | Director | Option Exercise | A | 0.44 | 75,000 | 33,000 | 75,000 | |
May 10 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | Lewis Michael E | Director | Option Exercise | A | 0.44 | 75,000 | 33,000 | 75,000 | |
May 10 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | Clerici John | Director | Option Exercise | A | 0.44 | 75,000 | 33,000 | 75,000 | |
May 10 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | Farah John M JR | Director | Option Exercise | A | 0.44 | 100,000 | 44,000 | 100,000 | |
May 10 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | KUMAR AMIT | Director | Option Exercise | A | 0.44 | 100,000 | 44,000 | 100,000 | |
May 10 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | RALLIS CHRIS A | Director | Option Exercise | A | 0.44 | 100,000 | 44,000 | 100,000 | |
Mar 11 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | SKIBSTED RUSSELL | Chief Financial Off ... | Option Exercise | A | 0.38 | 150,000 | 57,000 | 150,000 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | Lewis Michael E | Director | Option Exercise | A | 0.35 | 11,250 | 3,938 | 11,250 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | Lewis Michael E | Director | Option Exercise | A | 0.23 | 11,250 | 2,588 | 11,250 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | Lewis Michael E | Director | Option Exercise | A | 0.40 | 11,250 | 4,500 | 11,250 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | Lewis Michael E | Director | Option Exercise | A | 0.50 | 11,250 | 5,625 | 11,250 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | McManus John L | President and CEO | Buy | P | 0.35 | 10,000 | 3,500 | 80,300 | 70.3 K to 80.3 K (+14.22 %) |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | RALLIS CHRIS A | Director | Option Exercise | A | 0.25 | 3,750 | 938 | 3,750 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | RALLIS CHRIS A | Director | Option Exercise | A | 0.24 | 3,750 | 900 | 3,750 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | RALLIS CHRIS A | Director | Option Exercise | A | 0.35 | 11,250 | 3,938 | 11,250 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | RALLIS CHRIS A | Director | Option Exercise | A | 0.30 | 3,750 | 1,125 | 3,750 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | RALLIS CHRIS A | Director | Option Exercise | A | 0.23 | 11,250 | 2,588 | 11,250 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | RALLIS CHRIS A | Director | Option Exercise | A | 0.30 | 3,750 | 1,125 | 3,750 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | RALLIS CHRIS A | Director | Option Exercise | A | 0.31 | 11,250 | 3,488 | 11,250 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | RALLIS CHRIS A | Director | Option Exercise | A | 0.35 | 3,750 | 1,313 | 3,750 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | RALLIS CHRIS A | Director | Option Exercise | A | 0.40 | 3,750 | 1,500 | 3,750 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | RALLIS CHRIS A | Director | Option Exercise | A | 0.40 | 11,250 | 4,500 | 11,250 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | RALLIS CHRIS A | Director | Option Exercise | A | 0.44 | 3,750 | 1,650 | 3,750 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | RALLIS CHRIS A | Director | Option Exercise | A | 0.54 | 3,750 | 2,025 | 3,750 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | RALLIS CHRIS A | Director | Option Exercise | A | 0.40 | 3,750 | 1,500 | 3,750 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | RALLIS CHRIS A | Director | Option Exercise | A | 0.50 | 11,250 | 5,625 | 11,250 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | RALLIS CHRIS A | Director | Option Exercise | A | 0.80 | 3,750 | 3,000 | 3,750 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | RALLIS CHRIS A | Director | Option Exercise | A | 0.75 | 11,250 | 8,438 | 11,250 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | RALLIS CHRIS A | Director | Option Exercise | A | 0.60 | 3,750 | 2,250 | 3,750 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | Farah John M JR | Director | Option Exercise | A | 0.25 | 3,750 | 938 | 3,750 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | Farah John M JR | Director | Option Exercise | A | 0.24 | 3,750 | 900 | 3,750 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | Farah John M JR | Director | Option Exercise | A | 0.35 | 11,250 | 3,938 | 11,250 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | Farah John M JR | Director | Option Exercise | A | 0.30 | 3,750 | 1,125 | 3,750 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | Farah John M JR | Director | Option Exercise | A | 0.23 | 11,250 | 2,588 | 11,250 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | Farah John M JR | Director | Option Exercise | A | 0.30 | 3,750 | 1,125 | 3,750 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | Farah John M JR | Director | Option Exercise | A | 0.31 | 11,250 | 3,488 | 11,250 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | Farah John M JR | Director | Option Exercise | A | 0.35 | 3,750 | 1,313 | 3,750 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | Farah John M JR | Director | Option Exercise | A | 0.40 | 3,750 | 1,500 | 3,750 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | Farah John M JR | Director | Option Exercise | A | 0.40 | 11,250 | 4,500 | 11,250 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | Farah John M JR | Director | Option Exercise | A | 0.44 | 3,750 | 1,650 | 3,750 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | Farah John M JR | Director | Option Exercise | A | 0.54 | 3,750 | 2,025 | 3,750 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | Farah John M JR | Director | Option Exercise | A | 0.40 | 3,750 | 1,500 | 3,750 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | Farah John M JR | Director | Option Exercise | A | 0.50 | 11,250 | 5,625 | 11,250 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | Farah John M JR | Director | Option Exercise | A | 0.80 | 3,750 | 3,000 | 3,750 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | Suzdak Peter David | Director | Option Exercise | A | 0.35 | 11,250 | 3,938 | 11,250 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | Suzdak Peter David | Director | Option Exercise | A | 0.23 | 11,250 | 2,588 | 11,250 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | Suzdak Peter David | Director | Option Exercise | A | 0.31 | 11,250 | 3,488 | 11,250 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | Suzdak Peter David | Director | Option Exercise | A | 0.40 | 11,250 | 4,500 | 11,250 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | Suzdak Peter David | Director | Option Exercise | A | 0.50 | 11,250 | 5,625 | 11,250 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | KUMAR AMIT | Director | Option Exercise | A | 0.25 | 3,750 | 938 | 3,750 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | KUMAR AMIT | Director | Option Exercise | A | 0.24 | 3,750 | 900 | 3,750 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | KUMAR AMIT | Director | Option Exercise | A | 0.35 | 11,250 | 3,938 | 11,250 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | KUMAR AMIT | Director | Option Exercise | A | 0.30 | 3,750 | 1,125 | 3,750 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | KUMAR AMIT | Director | Option Exercise | A | 0.23 | 11,250 | 2,588 | 11,250 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | KUMAR AMIT | Director | Option Exercise | A | 0.30 | 3,750 | 1,125 | 3,750 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | KUMAR AMIT | Director | Option Exercise | A | 0.31 | 11,250 | 3,488 | 11,250 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | KUMAR AMIT | Director | Option Exercise | A | 0.35 | 3,750 | 1,313 | 3,750 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | KUMAR AMIT | Director | Option Exercise | A | 0.40 | 3,750 | 1,500 | 3,750 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | KUMAR AMIT | Director | Option Exercise | A | 0.40 | 11,250 | 4,500 | 11,250 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | KUMAR AMIT | Director | Option Exercise | A | 0.44 | 3,750 | 1,650 | 3,750 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | KUMAR AMIT | Director | Option Exercise | A | 0.54 | 3,750 | 2,025 | 3,750 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | KUMAR AMIT | Director | Option Exercise | A | 0.40 | 3,750 | 1,500 | 3,750 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | KUMAR AMIT | Director | Option Exercise | A | 0.50 | 11,250 | 5,625 | 11,250 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | KUMAR AMIT | Director | Option Exercise | A | 0.80 | 3,750 | 3,000 | 3,750 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | KUMAR AMIT | Director | Option Exercise | A | 0.60 | 3,750 | 2,250 | 3,750 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | Krivulka Joseph J | Director | Option Exercise | A | 0.35 | 11,250 | 3,938 | 11,250 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | Krivulka Joseph J | Director | Option Exercise | A | 0.23 | 11,250 | 2,588 | 11,250 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | Krivulka Joseph J | Director | Option Exercise | A | 0.31 | 11,250 | 3,488 | 11,250 | |
Mar 06 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | Krivulka Joseph J | Director | Option Exercise | A | 0.40 | 11,250 | 4,500 | 11,250 | |
Mar 05 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | McManus John L | President and CEO | Option Exercise | A | 0.40 | 2,000,000 | 800,000 | 2,000,000 | |
Feb 21 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Option Exercise | X | 0.01 | 11,785,714 | 117,857 | 0 | |
Feb 21 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Option Exercise | X | 0.01 | 43,614,285 | 436,143 | 0 | |
Feb 21 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Option Exercise | X | 0.01 | 1,875,000 | 18,750 | 0 | |
Feb 21 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Option Exercise | X | 0.01 | 1,875,000 | 18,750 | 0 | |
Feb 21 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Option Exercise | J | 0.01 | 11,785,714 | 117,857 | 11,785,714 | |
Feb 21 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Option Exercise | J | 0.01 | 43,614,285 | 436,143 | 43,614,285 | |
Feb 21 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Option Exercise | J | 0.01 | 1,875,000 | 18,750 | 1,875,000 | |
Feb 21 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Option Exercise | J | 0.01 | 1,875,000 | 18,750 | 1,875,000 | |
Feb 21 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Option Exercise | J | 0.28 | 11,785,714 | 3,300,000 | 0 | |
Feb 21 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Option Exercise | J | 0.28 | 43,614,285 | 12,212,000 | 0 | |
Feb 21 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Option Exercise | J | 0.50 | 1,875,000 | 937,500 | 0 | |
Feb 21 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Option Exercise | J | 0.50 | 1,875,000 | 937,500 | 0 | |
Feb 21 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Sell | S | 0.33 | 1,793,894 | 591,985 | 96,931,944 | 98.7 M to 96.9 M (-1.82 %) |
Feb 21 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | X | 0.00 | 59,149,999 | 0 | 98,725,838 | 39.6 M to 98.7 M (+149.46 %) |
Feb 20 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | Krivulka Joseph J | Director | Option Exercise | P | 0.25 | 400,000 | 100,000 | 400,000 | |
Feb 20 2013 | INCR.OB | AEOLUS PHARMACEUTI ... | Krivulka Joseph J | Director | Buy | P | 0.00 | 400,000 | 0 | 733,333 | 333.3 K to 733.3 K (+120.00 %) |
Jul 17 2012 | INCR.OB | AEOLUS PHARMACEUTI ... | McManus John L | President and CEO | Option Exercise | A | 0.28 | 250,000 | 70,000 | 250,000 | |
May 23 2012 | INCR.OB | AEOLUS PHARMACEUTI ... | SKIBSTED RUSSELL | Chief Financial Off ... | Buy | P | 0.24 | 7,027 | 1,678 | 17,027 | 10 K to 17 K (+70.27 %) |
Apr 06 2012 | INCR.OB | AEOLUS PHARMACEUTI ... | Krivulka Joseph J | Director | Option Exercise | P | 0.40 | 250,000 | 100,000 | 250,000 | |
Apr 06 2012 | INCR.OB | AEOLUS PHARMACEUTI ... | Krivulka Joseph J | Director | Buy | P | 0.30 | 333,333 | 100,000 | 333,333 | 0 to 333.3 K |
Oct 24 2011 | INCR.OB | AEOLUS PHARMACEUTI ... | RALLIS CHRIS A | Director | Option Exercise | A | 0.40 | 11,250 | 4,500 | 11,250 | |
Oct 24 2011 | INCR.OB | AEOLUS PHARMACEUTI ... | Lewis Michael E | Director | Option Exercise | A | 0.40 | 11,250 | 4,500 | 11,250 | |
Oct 24 2011 | INCR.OB | AEOLUS PHARMACEUTI ... | KUMAR AMIT | Director | Option Exercise | A | 0.40 | 11,250 | 4,500 | 11,250 | |
Oct 24 2011 | INCR.OB | AEOLUS PHARMACEUTI ... | Farah John M JR | Director | Option Exercise | A | 0.40 | 11,250 | 4,500 | 11,250 | |
Oct 24 2011 | INCR.OB | AEOLUS PHARMACEUTI ... | Krivulka Joseph J | Director | Option Exercise | A | 0.40 | 11,250 | 4,500 | 11,250 | |
Oct 24 2011 | INCR.OB | AEOLUS PHARMACEUTI ... | Suzdak Peter David | Director | Option Exercise | A | 0.40 | 11,250 | 4,500 | 11,250 | |
Oct 24 2011 | INCR.OB | AEOLUS PHARMACEUTI ... | McManus John L | President & CEO | Option Exercise | A | 0.40 | 250,000 | 100,000 | 250,000 | |
May 24 2011 | INCR.OB | AEOLUS PHARMACEUTI ... | McManus John L | President and CEO | Buy | P | 0.47 | 300 | 141 | 70,300 | 70 K to 70.3 K (+0.43 %) |
May 24 2011 | INCR.OB | AEOLUS PHARMACEUTI ... | McManus John L | President and CEO | Buy | P | 0.45 | 10,000 | 4,500 | 70,000 | 60 K to 70 K (+16.67 %) |
May 19 2011 | INCR.OB | AEOLUS PHARMACEUTI ... | McManus John L | President and CEO | Buy | P | 0.43 | 10,000 | 4,300 | 10,000 | 0 to 10 K |
May 19 2011 | INCR.OB | AEOLUS PHARMACEUTI ... | McManus John L | President and CEO | Buy | P | 0.43 | 10,000 | 4,300 | 60,000 | 50 K to 60 K (+20.00 %) |
May 19 2011 | INCR.OB | AEOLUS PHARMACEUTI ... | SKIBSTED RUSSELL | Chief Financial Off ... | Buy | P | 0.43 | 10,000 | 4,300 | 10,000 | 0 to 10 K |
May 19 2011 | INCR.OB | AEOLUS PHARMACEUTI ... | SKIBSTED RUSSELL | Chief Financial Off ... | Buy | P | 0.42 | 5,000 | 2,100 | 10,000 | 5 K to 10 K (+100.00 %) |
May 19 2011 | INCR.OB | AEOLUS PHARMACEUTI ... | SKIBSTED RUSSELL | Chief Financial Off ... | Buy | P | 0.41 | 5,000 | 2,050 | 5,000 | 0 to 5 K |
Mar 17 2011 | INCR.OB | AEOLUS PHARMACEUTI ... | Efficacy Capital, Ltd. | 10% Owner | Option Exercise | S | 0.75 | 2,541,000 | 1,905,750 | 3,235,281 | |
Mar 17 2011 | INCR.OB | AEOLUS PHARMACEUTI ... | Efficacy Capital, Ltd. | 10% Owner | Sell | S | 0.61 | 3,799,380 | 2,317,622 | 4,349,432 | 8.1 M to 4.3 M (-46.62 %) |
Mar 17 2011 | INCR.OB | AEOLUS PHARMACEUTI ... | Efficacy Capital, Ltd. | 10% Owner | Sell | S | 0.76 | 193,234 | 146,858 | 8,148,812 | 8.3 M to 8.1 M (-2.32 %) |
Mar 15 2011 | INCR.OB | AEOLUS PHARMACEUTI ... | McManus John L | President and CEO | Buy | P | 0.74 | 10,000 | 7,414 | 50,000 | 40 K to 50 K (+25.00 %) |
Feb 18 2011 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Sell | J | 0.00 | 882,488 | 0 | 39,575,839 | 40.5 M to 39.6 M (-2.18 %) |
Feb 18 2011 | INCR.OB | AEOLUS PHARMACEUTI ... | Cavalier David | Director | Sell | J | 0.00 | 882,488 | 0 | 39,748,589 | 40.6 M to 39.7 M (-2.17 %) |
Feb 18 2011 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Option Exercise | J | 0.40 | 2,500,000 | 1,000,000 | 0 | |
Feb 18 2011 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Option Exercise | X | 0.40 | 2,500,000 | 1,000,000 | 0 | |
Feb 18 2011 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Option Exercise | X | 0.50 | 2,500,000 | 1,250,000 | 2,500,000 | |
Feb 18 2011 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | X | 0.00 | 2,500,000 | 0 | 40,458,327 | 38 M to 40.5 M (+6.59 %) |
Feb 18 2011 | INCR.OB | AEOLUS PHARMACEUTI ... | Cavalier David | Director | Option Exercise | J | 0.40 | 2,500,000 | 1,000,000 | 0 | |
Feb 18 2011 | INCR.OB | AEOLUS PHARMACEUTI ... | Cavalier David | Director | Option Exercise | X | 0.40 | 2,500,000 | 1,000,000 | 0 | |
Feb 18 2011 | INCR.OB | AEOLUS PHARMACEUTI ... | Cavalier David | Director | Option Exercise | X | 0.50 | 2,500,000 | 1,250,000 | 2,500,000 | |
Feb 18 2011 | INCR.OB | AEOLUS PHARMACEUTI ... | Cavalier David | Director | Buy | X | 0.00 | 2,500,000 | 0 | 40,631,077 | 38.1 M to 40.6 M (+6.56 %) |
Feb 17 2011 | INCR.OB | AEOLUS PHARMACEUTI ... | Efficacy Capital, Ltd. | 10% Owner | Sell | S | 0.97 | 57,600 | 55,872 | 8,342,046 | 8.4 M to 8.3 M (-0.69 %) |
Feb 17 2011 | INCR.OB | AEOLUS PHARMACEUTI ... | Efficacy Capital, Ltd. | 10% Owner | Sell | S | 0.95 | 7,000 | 6,650 | 8,399,646 | 8.4 M to 8.4 M (-0.08 %) |
Feb 10 2011 | INCR.OB | AEOLUS PHARMACEUTI ... | Efficacy Capital, Ltd. | 10% Owner | Option Exercise | J | 0.75 | 604,258 | 453,194 | 5,776,281 | |
Feb 10 2011 | INCR.OB | AEOLUS PHARMACEUTI ... | Efficacy Capital, Ltd. | 10% Owner | Option Exercise | J | 0.75 | 479,461 | 359,596 | 6,380,539 | |
Feb 10 2011 | INCR.OB | AEOLUS PHARMACEUTI ... | Efficacy Capital, Ltd. | 10% Owner | Sell | J | 0.00 | 776,904 | 0 | 8,406,646 | 9.2 M to 8.4 M (-8.46 %) |
Feb 10 2011 | INCR.OB | AEOLUS PHARMACEUTI ... | Efficacy Capital, Ltd. | 10% Owner | Sell | J | 0.00 | 616,450 | 0 | 9,183,550 | 9.8 M to 9.2 M (-6.29 %) |
Jan 20 2011 | INCR.OB | AEOLUS PHARMACEUTI ... | Lewis Michael E | Director | Option Exercise | A | 0.75 | 11,250 | 8,438 | 11,250 | |
Jan 20 2011 | INCR.OB | AEOLUS PHARMACEUTI ... | KUMAR AMIT | Director | Option Exercise | A | 0.75 | 11,250 | 8,438 | 11,250 | |
Jan 20 2011 | INCR.OB | AEOLUS PHARMACEUTI ... | Krivulka Joseph J | Director | Option Exercise | A | 0.75 | 11,250 | 8,438 | 11,250 | |
Jan 20 2011 | INCR.OB | AEOLUS PHARMACEUTI ... | Suzdak Peter David | Director | Option Exercise | A | 0.75 | 11,250 | 8,438 | 11,250 | |
Jan 20 2011 | INCR.OB | AEOLUS PHARMACEUTI ... | Farah John M JR | Director | Option Exercise | A | 0.75 | 11,250 | 8,438 | 11,250 | |
Jan 20 2011 | INCR.OB | AEOLUS PHARMACEUTI ... | RALLIS CHRIS A | Director | Option Exercise | A | 0.75 | 11,250 | 8,438 | 11,250 | |
Dec 16 2010 | INCR.OB | AEOLUS PHARMACEUTI ... | Krivulka Joseph J | Director | Option Exercise | A | 0.60 | 11,250 | 6,750 | 11,250 | |
Dec 16 2010 | INCR.OB | AEOLUS PHARMACEUTI ... | RALLIS CHRIS A | Director | Option Exercise | A | 0.60 | 11,250 | 6,750 | 11,250 |